Literature DB >> 23820956

Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances.

Lei Huang1, Aman Xu, Tuanjie Li, Wenxiu Han, Shanshan Wu, Yangyi Wang.   

Abstract

Gastric carcinoma is one of the most common malignancies nowadays, and caner antigen 72-4 (CA 72-4) in gastric juice has been rarely studied. To compare CA 72-4 in gastric juice pre- and post-distal gastrectomy (DG) and analyze its possible significances, we selected 64 patients diagnosed with gastric carcinoma who underwent DG and collected their perioperative gastric juice samples whose contents of CA 72-4 were detected. We found that CA 72-4 in gastric juice pre-gastrectomy is significantly higher among patients in advanced stages and correlated with tumor TNM classification (P < 0.01), within which tumor size, levels of gastric wall invaded, and number of metastatic lymph nodes are significant influencing factors (P < 0.05); CA 72-4 in gastric juice post-gastrectomy is significantly higher than that pre-surgery (P < 0.01), and it is significantly correlated with tumor TNM classification and radical degree (P < 0.01), and regards the sum of distances from tumor to two cutting edges and the classification of cutting edge as significant impact factors (P < 0.05); nine patients whose CA 72-4 in gastric juice rose post-DG show features indicating poor prognosis; the difference of CA 72-4 in gastric juice between pre- and post-gastrectomy is significantly correlated with tumor TNM classification and radical degree (P < 0.05), and regards tumor size, levels of gastric walls invaded, the sum of distances from tumor to two cutting edges and the classification of cutting edge as significant influential factors (P < 0.05). We conclude that CA 72-4 in gastric juice pre- and post-gastrectomy can provide us with much information about tumor and radical gastrectomy and that CA 72-4 in gastric juice post-gastrectomy and the difference of CA 72-4 in gastric juice between pre- and post-gastrectomy may indicate prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820956     DOI: 10.1007/s12032-013-0651-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  7th edition of the AJCC cancer staging manual: stomach.

Authors:  Kay Washington
Journal:  Ann Surg Oncol       Date:  2010-12       Impact factor: 5.344

2.  The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.

Authors:  Shi Chen; Xing-Yu Feng; Yuan-Fang Li; Bai-Wei Zhao; Zhi-Wei Zhou; Ying-Bo Chen
Journal:  J Surg Oncol       Date:  2013-01-07       Impact factor: 3.454

3.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

4.  The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.

Authors:  Fangxuan Li; Rupeng Zhang; Han Liang; Hui Liu; Jichuan Quan; Jingzhu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-03       Impact factor: 4.553

5.  Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.

Authors:  Dae-Woon Eom; Gil Hyun Kang; Sang Hak Han; Gab Jin Cheon; Koon Hee Han; Ho-Suk Oh; Ji-Hun Kim; Hyuk-Jai Jang; Seung-Mo Hong
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

6.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer.

Authors:  R Hamazoe; M Maeta; T Matsui; S Shibata; S Shiota; N Kaibara
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

9.  Gastric juice miR-129 as a potential biomarker for screening gastric cancer.

Authors:  Xing Yu; Lin Luo; Yibo Wu; Xiuchong Yu; Yang Liu; Xuelin Yu; Xiaoyan Zhao; Xinjun Zhang; Long Cui; Guoliang Ye; Yanping Le; Junming Guo
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

10.  Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis.

Authors:  Sally Hopewell; Philippe Ravaud; Gabriel Baron; Isabelle Boutron
Journal:  BMJ       Date:  2012-06-22
View more
  14 in total

1.  Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.

Authors:  Danyi Mei; Haojun Song; Kai Wang; Yichao Lou; Weiliang Sun; Zhong Liu; Xiaoyun Ding; Junming Guo
Journal:  Med Oncol       Date:  2013-09-01       Impact factor: 3.064

Review 2.  Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.

Authors:  Lei Huang; Aman Xu
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.

Authors:  Lei Huang; A-Man Xu; Qiang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Adenocarcinoma of esophagogastric junction: controversial classification, surgical management, and clinicopathology.

Authors:  Lei Huang; A-Man Xu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

5.  Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance.

Authors:  Qianqian Pang; Jiaxin Ge; Yongfu Shao; Weiliang Sun; Haojun Song; Tian Xia; Bingxiu Xiao; Junming Guo
Journal:  Tumour Biol       Date:  2014-02-13

Review 6.  Epithelial-mesenchymal transition in gastric cancer.

Authors:  Lei Huang; Ruo-Lin Wu; A-Man Xu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 7.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases.

Authors:  A-Man Xu; Lei Huang; Liang Zhu; Zhi-Jian Wei
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

9.  The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis.

Authors:  Hui Li; Chunxiang Jiang; Dongwen Wu; Shupeng Shi; Mengting Liao; Jing Wang; Yanwen Li; Zihao Xu
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

10.  Expression and clinical significance of CD147 in renal cell carcinoma: a meta-analysis.

Authors:  Hui Li; Dongwen Wu; Shupeng Shi; Yadong Xu; Ling Wei; Jing Liu; Yanting Liu
Journal:  Oncotarget       Date:  2017-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.